Thomas Reiser/LinkedIn
Nov 20, 2025, 13:42
Rebalancing Therapies Poised to Transform Hemophilia Care․ Explore the New ISTH CME
Thomas Reiser, Executive Director of the International Society on Thrombosis and Haemostasis (ISTH), shared on X:
” New ISTH CME activity available:
Rebalancing Therapies for Hemophilia Are You Ready?
Gain the latest insights on emerg. rebalancing treatments, compare evolving clin. profiles & learn how to prepare your team for what’s next in hemophilia care.”
Read more here.
Stay updated with Hemostasis Today.
-
Nov 21, 2025, 14:26Haroun Gajraj: Stop Before You Inject Spider Veins Around the Ankle
-
Nov 21, 2025, 14:26Michael Makris: New UK Guideline on Acquired Coagulation Factor Inhibitors
-
Nov 21, 2025, 14:24William Wallace: Magnesium – Role in Blood Pressure Regulation
-
Nov 21, 2025, 14:23Mohamed Magdy Badr: How Do Acute Wounds Turn Into Chronic Wounds?
-
Nov 21, 2025, 14:22Ron DePinho: A Transformative Insight into Lupus – and the Virus Nearly All of Us Carry
-
Nov 21, 2025, 14:18Michael Bartholomew: Fix Your Mitochondria, Fix Almost Everything
-
Nov 21, 2025, 14:16Gianluca Franceschini on Fostering Innovation in Breast Cancer Care
-
Nov 21, 2025, 14:13Jon Faldasz: Ondansetron May Have Cardiotoxicity Risk Among 5-HT3RAs Due to High Concentration in Cardiac Tissues
-
Nov 21, 2025, 14:10Hortense Triniac Shares PhD Research: How Cortical Neurons Process and Activate tPA